PGP and breast cancer: This study highlights the significance of co-encapsulating a novel mitochondria depolarizer and Pgp efflux inhibitor, VES-H8R8, with a pH-sensitive prodrug of Dox in NPs to synergistically kill MDR breast cancer cells in vitro.